Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
As-needed Symbicort versus Bricanyl on background budesonide maintenance in mild-moderate asthma
ACTRN12622001304729Phase 4Completed
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in asthma comparing As-needed Symbicort plus maintenance Pulmicort with As-needed Bricanyl plus maintenance Pulmicort (2 arms). Primary endpoint: Fraction of exhaled nitric oxide. Started Mar 2023; status: completed.
02
Drugs
budesonideterbutaline
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12622001304729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001304729.